OBJECTIVE To develop and pilot a novel intervention addressing motivational and cognitive
barriers to avoiding hypoglycemia in people with type 1 diabetes and persistent impaired …

Impaired awareness of hypoglycaemia (IAH) is a major risk for severe hypoglycaemia in
insulin treatment of type 1 diabetes (T1D). To explore the hypothesis that unhelpful health …

OBJECTIVE Hypoglycemia unawareness (HU) affects ∼25% of people with type 1 diabetes.
People with HU are often reliant on family to detect hypoglycemia and treat severe episodes…

Some clinicians believe that antipsychotic depot injections are unacceptable to patients.
This cross-sectional study investigated patients’ attitudes regarding antipsychotics, and …

We investigated the adherence of mental health professionals to a Mindfulness-Based Cognitive
Therapy (MBCT) programme as well as the impact of MBCT on mindful awareness and …

Aims Sustained engagement in type 1 diabetes self‐management behaviours is a critical
element in achieving improvements in glycated haemoglobin (HbA1c) and minimising risk of …

OBJECTIVE Impaired awareness of hypoglycemia (IAH) and recurrent severe hypoglycemia
(RSH) remain problematic for people with type 1 diabetes (T1D), despite major therapeutic …

Objectives The effects of heart attack, or myocardial infarction ( MI ), across psychosocial
domains may be particularly acute in younger adults, for whom serious health events are non‐…

Aims/hypothesis Problematic hypoglycaemia still complicates insulin therapy for some with
type 1 diabetes. This study describes baseline emotional, cognitive and behavioural …

Background: Antipsychotic depot medications improve medication adherence by reducing
covert nonadherence, but some clinicians believe that they are unacceptable to patients. This …